NCT04562779View on ClinicalTrials.gov

Inpatient Single Dose Interventions for Alcohol Use Disorder

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

January 19, 2021

Primary Completion Date

January 1, 2022

Study Completion Date

February 1, 2022

Conditions
Alcohol Use Disorder, Severe
Interventions
DRUG

Naltrexone 380 MG

XR naltrexone to be given once prior to hospital discharge

DRUG

Ketamine Hydrochloride

IV ketamine infusion to be given once prior to hospital discharge

BEHAVIORAL

Enhanced linkage

Includes in-hospital intake at outpatient addiction clinic plus contingency management related to follow-up

Trial Locations (1)

80204

Denver Health Medical Center, Denver

All Listed Sponsors
lead

Denver Health and Hospital Authority

OTHER

NCT04562779 - Inpatient Single Dose Interventions for Alcohol Use Disorder | Biotech Hunter | Biotech Hunter